re not
necessarily indicative of our operating results for any future periods. Any
projections in this release are based on limited information currently
available to us, which is subject to change. Although such projections and
the factors influencing them will likely change, we will not necessarily
update the information. Such information speaks only as of the date of this
release.
For more information, please contact:
In the U.S.:
Evan Smith
Managing Director, FD
Tel: +1-212-850-5606
Email: evan.smith@fd.com
John Capodanno
Senior Vice President, FD
Tel: +1-212-850-5705
Email: john.capodanno@fd.com
In China:
May Li
Mindray Investor Relations
Tel: +86-755-2658-2518
Email: may.li@mindray.com
MINDRAY MEDICAL INTERNATIONAL LIMITED
CONDENSED CONSOLIDATED BALANCE SHEETS
As at December 31, As at June 30,
2007 2008
US$ US$
(unaudited) (unaudited)
ASSETS (In thousands) (In thousands)
Current assets:
Cash and cash equivalents 189,045 74,999
Restricted cash -- 69,980
Short-term investments 55,897 80,402
Accounts receivable, net 28,813 72,501
Inventories 24,816 60,758
Other receivables 5,400 7,289
Prepayments and other 1,92
'/>"/>
SOURCE Mindray Medical International Limited Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Related biology technology :1.
Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference2.
Mindray Announces Appointment of Dr. Jixun Lin as Independent Director3.
Mindray Medical International Announces Third Quarter 2007 Results4.
Mindray to Acquire Datascopes Patient Monitoring Business for US$202 million5.
Mindray Medical International Announces First Quarter 2008 Results6.
Mindray Medical to Attend Morgan Stanley Global Healthcare Unplugged Conference7.
AEterna Zentaris completes management team with the appointment of Chief Medical Officer8.
VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent9.
China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day10.
Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth11.
BioMS Medical announces its intention to renew a normal course issuer bid